Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation.

P J Morris1

  • 1Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, UK.

British Medical Bulletin
|March 21, 2000
PubMed
Summary
This summary is machine-generated.

Xenotransplantation, using animal organs like pigs, faces many challenges. Genetic engineering has theoretically solved hyperacute rejection, but other hurdles remain for clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The immunobiology of cell transplantation.

Transplantation proceedings·1992
Same author

The role of T suppressor cells in the maintenance of spontaneously accepted orthotopic rat liver allografts.

Transplantation·1992
Same author

Immunological advances in clinical transplantation.

Transplantation proceedings·1992
Same author

Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.

Transplantation proceedings·1992
Same author

Diabetes and frontiers of research. Introduction.

Diabetologia·1992
Same author

Reductive debromination of the commercial polybrominated biphenyl mixture firemaster BP6 by anaerobic microorganisms from sediments.

Applied and environmental microbiology·1992
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Genetic engineering in medicine

Background:

  • Growing organ transplant success leads to increased demand and organ donor shortages.
  • Investigating animal organs, particularly from pigs, as a potential solution for organ scarcity.
  • Xenotransplantation faces significant immunological, physiological, anatomical, infectious, and ethical barriers.

Purpose of the Study:

  • To address the critical immunological barrier in xenotransplantation, specifically hyperacute rejection.
  • To explore the potential of genetic engineering to overcome xenograft rejection.
  • To review the current status and remaining challenges in making xenotransplantation a clinical reality.

Main Methods:

  • Focus on the immunological aspects of xenotransplantation, particularly hyperacute rejection.

Related Experiment Videos

  • Application of genetic engineering to modify donor animals (e.g., pigs) to reduce antibody-mediated rejection.
  • Analysis of the galactose alpha-1,3-galactose antigen as a primary target for immune attack.

    • Main Results:

    • Genetic engineering has theoretically resolved the issue of hyperacute rejection caused by anti-galactose antibodies.
    • The primary immunological barrier, mediated by natural cytotoxic antibodies, has been addressed through genetic modification.
    • Significant progress has been made in overcoming the immediate immunological rejection in xenotransplantation.

    Conclusions:

    • While genetic engineering offers a theoretical solution to hyperacute rejection, xenotransplantation still faces numerous unresolved challenges.
    • Further research is required to overcome physiological, anatomical, infectious, and ethical barriers before clinical application.
    • Xenotransplantation is not yet a clinical reality despite advancements in addressing immunological incompatibilities.